Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.
The start of the '20s offers the industry an opportunity to build value through new tech., collaborations, clinical validations, and value-based outcomes.
Acquisition will add to TE’s integrated sensor solutions offering in medical, transportation, and industrial applications for a wide range of global customers.